ANTIBODIES THAT BIND AND BLOCK TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-1 (TREM-1)
There is provided antibodies that are capable of specifically binding TREM-1 and preventing the activation of TREM-1, a protein expressed on monocytes, macrophages, and neutrophils. Such antibodies find utility in the treatment of individuals with an inflammatory disease.
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
31.07.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | There is provided antibodies that are capable of specifically binding TREM-1 and preventing the activation of TREM-1, a protein expressed on monocytes, macrophages, and neutrophils. Such antibodies find utility in the treatment of individuals with an inflammatory disease. |
---|---|
Bibliography: | Application Number: EP20170156557 |